These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22398080)

  • 1. Temporal trends in colon neoplasms in patients with primary sclerosing cholangitis and ulcerative colitis.
    Navaneethan U; Venkatesh PG; Lashner BA; Remzi FH; Shen B; Kiran RP
    J Crohns Colitis; 2012 Sep; 6(8):845-51. PubMed ID: 22398080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration and severity of primary sclerosing cholangitis is not associated with risk of neoplastic changes in the colon in patients with ulcerative colitis.
    Navaneethan U; Kochhar G; Venkatesh PG; Lewis B; Lashner BA; Remzi FH; Shen B; Kiran RP
    Gastrointest Endosc; 2012 May; 75(5):1045-1054.e1. PubMed ID: 22405258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
    J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
    Navaneethan U; Kochhar G; Venkatesh PG; Bennett AE; Rizk M; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Brentnall TA; Haggitt RC; Rabinovitch PS; Kimmey MB; Bronner MP; Levine DS; Kowdley KV; Stevens AC; Crispin DA; Emond M; Rubin CE
    Gastroenterology; 1996 Feb; 110(2):331-8. PubMed ID: 8566577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Active Inflammation in the Colon is Not a Reliable Predictor of an Elevated Risk of Dysplasia in Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis.
    Zhang R; Wang D; Lauwers GY; Choi WT
    Am J Surg Pathol; 2024 Sep; 48(9):1154-1163. PubMed ID: 38809303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?
    Marelli L; Xirouchakis E; Kalambokis G; Cholongitas E; Hamilton MI; Burroughs AK
    Gut; 2011 Sep; 60(9):1224-8. PubMed ID: 21402617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis.
    Marchesa P; Lashner BA; Lavery IC; Milsom J; Hull TL; Strong SA; Church JM; Navarro G; Fazio VW
    Am J Gastroenterol; 1997 Aug; 92(8):1285-8. PubMed ID: 9260790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.
    Broomé U; Bergquist A
    Semin Liver Dis; 2006 Feb; 26(1):31-41. PubMed ID: 16496231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
    Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated immunoglobulin G4 level is associated with reduced colectomy-free survival in patients with primary sclerosing cholangitis and ulcerative colitis.
    Navaneethan U; Venkatesh PG; Choudhary M; Shen B; Kiran RP
    J Crohns Colitis; 2013 Mar; 7(2):e35-41. PubMed ID: 22554774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
    Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
    Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation.
    Loftus EV; Aguilar HI; Sandborn WJ; Tremaine WJ; Krom RA; Zinsmeister AR; Graziadei IW; Wiesner RH
    Hepatology; 1998 Mar; 27(3):685-90. PubMed ID: 9500695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of ulcerative colitis on the long-term outcome of patients with primary sclerosing cholangitis.
    Navaneethan U; Venkatesh PG; Lashner BA; Shen B; Kiran RP
    Aliment Pharmacol Ther; 2012 May; 35(9):1045-53. PubMed ID: 22428605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon.
    Krugliak Cleveland N; Rubin DT; Hart J; Weber CR; Meckel K; Tran AL; Aelvoet AS; Pan I; Gonsalves A; Gaetano JN; Williams KM; Wroblewski K; Jabri B; Pekow J
    Clin Gastroenterol Hepatol; 2018 Jan; 16(1):68-74. PubMed ID: 28756053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fate of indefinite and low-grade dysplasia in ulcerative colitis and primary sclerosing cholangitis colitis before and after liver transplantation.
    Eaton JE; Smyrk TC; Imam M; Pardi DS; Loftus EV; Owens VL; Talwalkar JA
    Aliment Pharmacol Ther; 2013 Oct; 38(8):977-87. PubMed ID: 24033551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential.
    Broomé U; Löfberg R; Veress B; Eriksson LS
    Hepatology; 1995 Nov; 22(5):1404-8. PubMed ID: 7590655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study.
    Terg R; Sambuelli A; Coronel E; Mazzuco J; Cartier M; Negreira S; Muñoz A; Gil A; Miguez C; Huernos S; Romero G; Goncalvez S; Levi D; Abecasis R
    Acta Gastroenterol Latinoam; 2008 Mar; 38(1):26-33. PubMed ID: 18533354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea.
    Ye BD; Yang SK; Boo SJ; Cho YK; Yang DH; Yoon SM; Kim KJ; Byeon JS; Myung SJ; Yu CS; Yun SC; Kim JH
    Inflamm Bowel Dis; 2011 Sep; 17(9):1901-6. PubMed ID: 21830268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia.
    Torres J; Bao X; Iuga AC; Chen A; Harpaz N; Ullman T; Cohen BL; Pineton de Chambrun G; Asciutti S; Odin JA; Sachar DB; Gaskins HR; Setchell K; Colombel JF; Itzkowitz SH
    Inflamm Bowel Dis; 2013 Feb; 19(2):275-82. PubMed ID: 23348121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.